Leptin is an anorexigenic hormone produced by adipose tissue, and is one component of a complex regulatory pathway that acts to maintain energy homeostasis in mammals (40, 53) . Treatment of infertile ob/ob mice with recombinant leptin not only leads to a loss of food intake and body weight, but also restores fertility, suggesting that adequate plasma leptin concentrations are also essential for normal reproductive function (7, 38) . During pregnancy, especially in the second and third trimesters, maternal plasma levels of leptin are significantly elevated in numerous mammalian species, including humans (14, 16, 20, 21, 28, 29) . These observations, together with the presence of the signaling form of the leptin receptor in feto-placental tissues (3, 20) , has led to the suggestion that leptin may play roles in the maintenance of fertility, pregnancy, fetal and placental growth, and development.
Unlike in non-pregnant animals, elevated plasma leptin levels during pregnancy are not always correlated with adiposity (13, 16, 50) . This led us to propose that leptin secretion from adipose tissue may be upregulated during pregnancy. We have since demonstrated that upregulation of leptin secretion from adipose tissue occurs in pregnant mice (28) and to a much lesser extent in little brown bats, but not in big brown bats (29) . The lack of pronounced upregulation of leptin secretion from adipose tissue in vitro in pregnant bats led us to test the hypothesis that the placenta was a source of leptin secretion in bats. The rationale for this hypothesis was based on recent demonstrations that leptin mRNA is present in placentae of humans and baboons (20) , and leptin is secreted from cultured human choriocarcinoma cells (37) . We demonstrated that leptin was constitutively secreted by placentae of Myotis lucifugus, the little brown bat, but not by mouse placentae incubated in vitro (28, 29) . Whether placental leptin secretion is regulated, and whether the placenta of M. lucifugus synthesizes leptin transcript, however, remains unknown. In addition, it remains unresolved whether the placenta is a site of leptin expression in rodents (23, 27, 28) .
In the present study, leptin expression during pregnancy was examined in several species representing the two most abundant mammalian orders, Rodentia and Chiroptera, and in human choriocarcinoma cells. Rodents and bats comprise roughly 50% and 20% of all known mammalian species, respectively (51), and are not closely related taxonomically (44) . The little brown bat, M.
lucifugus, is one of the most abundant and widely distributed insectivorous bats in North America (25) .
In New England, this species is active from April through September and hibernates for the rest of the year. Mating occurs in autumn and sperm is stored in the female's reproductive tract during hibernation (5) . Ovulation and fertilization occur upon arousal from hibernation in spring (25) , and gestation lasts about 60 days with one offspring produced each year (34) . During pregnancy, greatly increased leptin levels are observed in maternal blood (29, 32, 50) . Parturition begins around mid-June and is highly synchronized within a given colony. Litter size accounts for almost 25% of adult body mass (31) , and pups reach 84% of adult size by the end of lactation (30) . Thus, during pregnancy and lactation little brown bats face extraordinary energy demands, and leptin would be expected to be tightly controlled during these periods.
Using Mus musculus and Myotis lucifugus as model species, the objectives of this study were to: 1) determine whether the rodent and bat placentae are capable of synthesizing leptin mRNA transcript, 2) determine if placental leptin expression and secretion are under regulatory control, and 3) establish the gestational profile and tissue distribution of leptin mRNA in M. lucifugus. Based in part on our earlier observations (28, 29) , we hypothesized that the placenta of M. lucifugus, but not Mus musculus, would express leptin transcript, that leptin transcript in the placenta would be expressed throughout the course of gestation, and that leptin expression would be primarily restricted to adipose and placental tissue.
Materials and Methods

Collection of animals and tissues
Little brown bats (Myotis lucifugus) were collected from maternity colonies in eastern Massachusetts from late May to late June over four seasons (1999) (2000) (2001) (2002) . Bats were captured with a harp trap from 2100-2300h as they returned from foraging, and transferred to the laboratory in simulated roosts without food, as previously described (33 
In vitro incubation
Placentae from bats between 23-48 days prior to parturition (as determined by the above equation)
were weighed, dissected in half, and then each half was separately minced with a razor into ~1mm 3 cubes.
Placental fragments were washed with several changes of 1000 volume-equivalents of cold, serum-free Leptin concentrations in culture media were determined by radioimmunoassay using a human leptin kit (Linco Research, Inc.) that we have previously validated for M. lucifugus plasma leptin (29, 32, 50) .
Dehydrated media were first reconstituted to 10% original volume, which was empirically determined to result in leptin measurements that fell on the linear portion of the human leptin standard curve.
Immunoreactive leptin was at or below the limit of detection in blank samples of reconstituted culture medium.
Human choriocarcinoma (BeWo) cells were obtained from American Type Tissue Culture and grown in RPMI 1640 culture medium (Gibco) supplemented with 10% heat-inactivated fetal calf serum, 100 U/ml penicillin, 100 µg/ml streptomycin, and 2mM glutamine. Cells were cultured in the presence of vehicle (butyric acid) or 1 mM dibutyryl cAMP for six days. Media were collected and replaced daily. A portion of the collected media from each culture dish was dried in a Centrivap concentrator and reconstituted to 10% original volume for radioimmunoassay of leptin using the human leptin RIA kit from Linco. Cells were harvested at the end of the sixth day in culture and total RNA was extracted with
Trizol reagent. rtPCR analysis of leptin transcripts was performed as above.
Northern blot analyses
PolyA RNA was extracted using the Oligotex Direct mRNA kit from Qiagen. Ten µg polyA RNA was run for 3h on formaldehyde 1% agarose gels at 40mV, then transferred to nylon membranes 
rtPCR and Sequencing
The following custom-made primers were used for reverse transcriptase-polymerase chain reaction (rtPCR) and sequencing. Forward primer 1 (5'-GRTTCYTGTGGCTTTGGYCCTATC-3') was a degenerate primer corresponding to a highly conserved region of human, mouse, rat, dog, and cat leptin cDNA, and extended into the 5'-flanking region. Forward primer 2 (5'-ARRGTCCARGATGACACCAAAACCC-3') was a degenerate primer whose origin was within the coding region of leptin cDNA. Both forward primers were used in separate reactions with the same reverse direction primer (5'-GCCACCACCTCBGTGGAGTAG-3'). Fragments of 415 and 362 bp were expected to be generated with forward primers 1 and 2, respectively. No sequence similarity in the primers was found in the database other than leptin sequences from different species. The primers spanned an intron of ~1.7kb in the mouse leptin gene (19) .
Total RNA from placenta was extracted using Trizol reagent. Two µg total RNA was reverse transcribed using the leptin-specific reverse primer (above) and a Reverse Transcription kit (Promega)
according to the manufacturer's protocol. Polymerase chain reactions were performed in a PTC-100 thermal cycler (MJ Research Inc.) with the following conditions:
Step 1: 94°C for 1 minute;
Step 2: [94°C for 40 seconds, 55°C for 40 seconds, 72°C for 2 minutes] total 38 cycles;
Step 3: 72°C for 2 minutes.
These conditions were determined to be optimal for assessing the presence or absence of leptin transcript, which is not abundantly expressed in most tissues. PCR products were electrophoresed on 1.5% lowmelt agarose gels in the presence of ethidium bromide and visualized under UV light. Products corresponding to the expected leptin cDNA fragment were excised from the gel, and subcloned into a TA cloning vector (Invitrogen). Sequencing reactions were performed using BigDye Terminator Cycler Sequencing Ready Reaction Kit (Perkin-Elmer) and Applied Biosystems 377 automated DNA Sequencer.
For all other PCR reactions, forward primer 2 and the reverse primer were used for amplifying leptin transcripts in bat and mouse tissue extracts. In some experiments, control tubes were included in which PCR was performed without the reverse transcription step. No PCR products were observed under these conditions (not shown), suggesting that RNA samples did not contain significant contamination with genomic DNA. Lack of contamination was further suggested by the size of the PCR product relative to the expected size that would include the intervening intron.
Conditions for semi-quantitative PCR using beta-actin transcript were the same as above except for the number of amplification cycles. It was determined that 25 amplification cycles resulted in actin transcript signal within the exponential increase and before the plateau in reaction product, and that 33 cycles resulted in exponential increase of leptin reaction product (not shown). The primer pair for β-actin was purchased from Promega; a fragment of 285 bp was expected. PCR products were electrophoresed on 1% agarose gels in the presence of ethidium bromide and visualized with a digital imaging system from Molecular Analysis (Bio-Rad). Semi-quantitative assessments of RNA transcript expression were made using the ratio between leptin and β-actin. Product intensities were analyzed using the NIH ImageJ software.
Miscellaneous
Cortisol in plasma of M. lucifugus was determined using a commercial radioimmunoassay from ICN, which we have previously validated for bat plasma (48, 49) . Immunoblots for detection of glucocorticoid receptor were performed using rabbit anti-human glucocorticoid receptor antiserum (Santa Cruz Biotechnologies, Inc.) at a dilution of 1:100. Several hypothalami were pooled to obtain sufficient starting material. Detection of signal was performed with goat anti-rabbit IgG (1:4000) conjugated to horseradish peroxidase (Sigma), and Western Lightening Chemiluminescence Reagent Plus (PerkinElmer).
ANOVAs or t-tests were used to test for significant differences among treatment groups using PRISM software (GraphPad, Inc.); significant differences were considered to exist when p<0.05.
Results
Expression of leptin transcript in placenta
To investigate expression of leptin in bats, we first designed a 38-mer oligonucleotide probe that was 100% homologous among human, mouse, and rat leptin cDNA, and that resided within the highly Placental mRNA from early, middle and late gestation M. lucifugus was hybridized with the probe described above. The blots revealed a single placental transcript of ~2.3 kb (Fig. 1A) , identical to the size of the transcript in M. lucifugus adipose tissue. After normalizing the data to β-actin expression, there was no significant change in leptin mRNA expression per unit mass placenta from early to late gestation (Fig. 1B) . Thus, leptin transcript was expressed in M. lucifugus placenta in high amounts throughout gestation.
Stimulation of leptin secretion from M. lucifugus placenta
Once it was established that leptin transcript was expressed in bat placenta, we examined control of leptin secretion from placental fragments in vitro. Preliminary experiments confirmed our published report (29) that leptin is secreted from placentae of M. lucifugus, and also demonstrated that the secretion was increased by cAMP (not shown). In addition, cAMP significantly stimulated secretion of leptin from cultured human choriocarcinoma cells (Figure 2A) , and also significantly increased leptin mRNA in the cells ( Figure 2B ).
Glucocorticoids potently stimulate leptin synthesis and secretion from adipose tissue cells (28, 39) , and are important metabolic hormones during pregnancy. The hypothesis that glucocorticoids may stimulate placental leptin production was tested using placental fragments from M. lucifugus incubated with natural (corticosterone) or synthetic (dexamethasone) steroids for up to eight hours. Because the gestational profile of plasma glucocorticoids in any chiropteran species was unknown, however, we first determined cortisol (the major glucocorticoid in M. lucifugus) levels in plasma of pregnant bats. Plasma cortisol ranged between approximately 50-350 ng/ml (~0.14 µM to 1 µM) in pregnant bats over the course of gestation (n=41, data not shown), compared to ~15-170 ng/ml in post-lactational M. lucifugus (48) . Using a range of concentrations (10 nM to 10 µM) spanning and exceeding those measured in pregnant M. lucifugus, however, we could not detect any effect of natural or synthetic glucocorticoids on leptin secretion or mRNA production in placental fragments from M. lucifugus (not shown). Failure to observe effects of glucocorticoids was not due to the absence of placental glucocorticoid receptors, since immunoblots revealed the presence of receptors in M. lucifugus placenta (Fig. 3) .
Leptin expression profile in M. lucifugus
Tissue-distribution of leptin mRNA was examined in M. lucifugus using rtPCR analysis of total RNA from adipose tissue, placenta, heart, liver, kidney, spleen, brain and lung from late-gestation females.
Leptin transcript was detected in adipose and placental tissue, with barely detectable levels in heart, liver and spleen, and below detectable levels in lung, kidney and brain (Fig. 4 A and B) . These results were confirmed in a replicate analysis (not shown) with tissue from different animals, except that the amount of expression (relative to that in adipose and placental tissue) was greater in heart and spleen than shown in figure 4A .
Because leptin mRNA is expressed in avian liver (46), but not in any known adult mammal, further studies were performed to verify the presence of leptin mRNA in M. lucifugus liver as seen in Figure 4A . rtPCR analysis of hepatic tissue from several individual little brown bats and a related species, Eptesicus fuscus, revealed expression of a single PCR product that corresponded to the predicted size of the partial leptin transcript (Fig. 4 C, D) . No expression of leptin transcript was present in either mouse or rat liver (Fig. 4 E, F) . There was, however, expression of leptin transcript in rat placenta, but no detectable expression in mouse placenta (Fig. 6 E) . Northern blot analysis of hepatic mRNA from M. lucifugus detected a single transcript in liver that corresponded in size to that expressed in placenta (Fig. 5) . The Because rtPCR analysis was performed with degenerate primers based on the mouse leptin cDNA sequence, the results were verified by cloning and sequencing leptin cDNA from M. lucifugus placenta and using the sequence to generate a bat-specific oligonucleotide probe. A composite M. lucifugus leptin cDNA sequence was generated by directly sequencing several rtPCR products and several different subclones. This sequence (submitted to GenBank and assigned an assession number of AY055474)
represented ~80% of the predicted coding region, and was 87% homologous to human and 84%
homologous at the nucleotide level to rat and mouse leptin cDNA's. Based on this sequence, an homologous oligonucleotide probe corresponding to the probe used in Figures 1 and 5 (differing by 2 nts) was generated for use in Northern blots. As with the degenerate probes, a single transcript of 2.3kb was observed on Northern blots of adipose and placental tissue (data not shown).
Discussion
In addition to its metabolic and anorexigenic actions, leptin is believed to have several important functions related to reproduction (3, 22) . We recently demonstrated that in M. lucifugus, there is a progressive increase in maternal plasma leptin levels throughout pregnancy, followed by a rapid decrease after parturition (29) , as observed in other species (3, 20) . Elevated leptin levels of pregnancy in mammals are not usually correlated with adiposity (29), unlike in non-pregnant mammals in whom increased adipose mass is associated with increased circulating leptin (36) . We previously reported that in pregnant mice, dissociation of circulating leptin from adipose mass appears to result from upregulation of adipose leptin secretion, possibly due to the influence of circulating steroid hormones (28) . In other species, however, such as baboons (24), bats (29) , and humans (37), adipose leptin production appears to be only partly responsible for the increase in circulating leptin in maternal blood. In those species, it has been postulated that the placenta may play a key role in contributing to maternal leptin levels.
Here, we demonstrate that placental expression of leptin transcript is species-specific, even within the same order of mammals. We chose to examine rodents and bats because members of these orders collectively comprise ~70% of all mammalian species (51), and are not closely related taxonomically (20), we conclude that leptin expression appears to be a common feature of placental physiology in mammals, but it is nonetheless not a ubiquitous feature. Thus, it appears that generalities about placental leptin expression must be tempered at this time, since related species within a single family may not all express and secrete leptin from the placenta. What is clear is that there are at least three mechanisms in mammals by which maternal leptin levels are increased. First, as in mice, adipose tissue leptin expression and secretion are greatly upregulated. Second, as in little brown bats and primates, placental leptin expression is increased and the placenta secretes leptin (production of adipose leptin may still be increased in these pregnant animals). Third, as in mice and humans, the placenta secretes a soluble form of the leptin receptor into the circulation, which may act to prolong the half-life of leptin in plasma, contributing to higher circulating levels (16, 35, 52) .
The placentae of certain species, such as humans (20), baboons (20) , and little brown bats (Zhao, Kunz, Li, Clamon Schulz, and Widmaier, unpublished), express the active form of the leptin receptor, OB-Rb. Together with the ability of the placenta to produce and secrete leptin, this suggests that the placenta may be a target organ for leptin, and that placental leptin may have autocrine or paracrine activities. Indeed, leptin has been suggested to regulate placental growth and angiogenesis (3), function as a local immunomodulator (22) , and possibly to play a role in implantation by modulating expression of extracellular matrix-degrading enzymes (3).
The size of the leptin mRNA transcript in M. lucifugus was smaller than that in the mouse (and other species, 27, 37). The reason for this difference is unknown. However, leptin mRNA contains a long 3' untranslated region (53), which may be important for regulating message half-life as has been reported for other transcripts with such regions (e.g., estradiol receptor transcript, 42). It is not possible to say at this time, however, whether the shortened 3'-UTR of the bat leptin mRNA plays a role in stability of the transcript.
We previously reported that leptin accumulates in media of placental fragments from M. lucifugus incubated in vitro in the absence of any stimulus (29) . We report here that the secretion of leptin from M.
lucifugus placenta may be regulated, since it was stimulated by cAMP in preliminary experiments. This finding is consistent with a previous report in human placentae (9) . Cultured human choriocarcinoma cells also secreted leptin under the influence of cAMP in the present study. One difference between the bat and the human tumor cells, however, was that cAMP stimulated expression of leptin transcript in the tumor cells, but not in the placental fragments. Although this may be a true species-specific function of cAMP, it is also possible that the effect of cAMP on the bat placenta requires a time interval longer than was feasible using acutely minced placental fragments. Notwithstanding, it appears that cAMP exerts tissue-specific actions on leptin, since cAMP is believed to mediate the inhibitory effects of ß 3 -adrenergic receptor activation on adipose leptin secretion (17) , yet stimulates placental leptin secretion. Placentalspecific enhancer regions and stimulatory transcription factors have, in fact, been identified in human placenta (4).
Glucocorticoids potently stimulate leptin production and secretion from adipose cells (28, 39) , and mammalian placentae express glucocorticoid receptors in trophoblast cells (12) . Thus, we tested the hypothesis that glucocorticoids would stimulate placental leptin expression and secretion, but were unable to demonstrate any effect of natural or synthetic glucocorticoids on M. lucifugus placentae. This was true that placental leptin expression increases as gestation advances in humans and rats (10, 15) and decreases from early to late gestation stages in baboons (21), indicating that not only the expression of placental leptin, but also its temporal pattern of expression during pregnancy are species-specific.
Other than adipose and placental tissue, leptin is also expressed in pituitary (26) Leptin has been cloned or partially sequenced in several species including human, rat and mouse (53) , and big brown bats (11) . The nucleotide sequence of M. lucifugus leptin cDNA ranged from 79% to 95% homology with reported sequences for other eutherian mammals. Leptin was strongly expressed in adipose and placental tissue of the little brown bat, and moderately in liver, heart and spleen. It is not known whether leptin expression in placenta, liver, heart, and spleen was due to the presence of a small M. musculus M. lucifugus Figure 5 
